Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00978939 · ClinicalTrials.gov registry record · Phase 4
Impact of Aggressive Versus Standard Drainage Regimen Using a Long Term Indwelling Pleural Catheter
A Phase 4 study of Pleural Effusion, Malignant, sponsored by Duke University.
- Completed
- Registry status
- Phase 4
- Development phase
- 150
- Enrollment target
- 6
- Study locations
NCT00978939 is a Phase 4 study of Pleural Effusion, Malignant that has completed, run by Duke University. The registered enrollment target is 150 participants, below the 170-participant average among 3 other Pleural Effusion, Malignant trials with a reported enrollment target (12% lower). The trial reports 6 study locations across 5 states.
The verdict
NCT00978939, a Phase 4 study of Pleural Effusion, Malignant, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 150 participants
- Enrollment target
- 6
- Study locations
Study Summary
Purpose and Objective: The purpose of this study is to determine if the rate of spontaneous pleurodesis using the Pleurx® catheter could be increased by simply increasing the frequency of pleural drainage and, if so, whether catheter-related complications can be minimized and spare patients the need for long term management of the Pleurx® catheter.
Conditions Studied
Interventions
- OTHER Standard Drainage Instructions
- OTHER Aggressive Drainage Instructions
Study Locations (6)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
- Lahey Clinic - Burlington
Colorado
- National Jewish Medical Center - Denver
Maryland
- Johns Hopkins University - Baltimore
North Carolina
- Duke University Medical Center - Durham
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2009-08 |
| Est. Completion | 2013-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00978939
The ClinicalTrials.gov registry entry for NCT00978939 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 170-participant average among 3 other Pleural Effusion, Malignant trials with a reported enrollment target (12% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pleural Effusion, Malignant appearing as the primary indexed condition, and to 2 interventions - of which Standard Drainage Instructions is the first listed.
NCT00978939 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Massachusetts, Colorado, Maryland.
Frequently Asked Questions
What is clinical trial NCT00978939 about?
NCT00978939 is a clinical study titled "Impact of Aggressive Versus Standard Drainage Regimen Using a Long Term Indwelling Pleural Catheter". Purpose and Objective: The purpose of this study is to determine if the rate of spontaneous pleurodesis using the Pleurx® catheter could be increased by simply increasing the frequency of pleural drainage and, if so, whether catheter-related complications can be minimized and spare patients the need...
What is the current status of trial NCT00978939?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2009-08. Estimated completion is 2013-10.
What conditions does trial NCT00978939 study?
This clinical trial studies the following conditions: Pleural Effusion, Malignant.
What interventions are being tested in trial NCT00978939?
The interventions under investigation include: Standard Drainage Instructions (OTHER), Aggressive Drainage Instructions (OTHER).
Who is sponsoring clinical trial NCT00978939?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00978939 being conducted?
This trial has 6 study locations across Colorado, Maryland, Massachusetts, North Carolina, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pleural Effusion, Malignant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.